Last reviewed · How we verify
NCT05246683: LATIN-SHOCK
LATIN SHOCK: Latin American Registry of Cardiogenic Shock in the Context of Acute Coronary Syndrome
trial testing observational in Cardiogenic Shock in 700 participants. Status unknown.
18 December 2022
Quick facts
| Lead sponsor | Sociedad Argentina de Cardiología |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 700 |
| Start date | 15 February 2022 |
| Primary completion | 18 December 2022 |
| Estimated completion | 18 December 2022 |
| Sites | 1 location across Argentina |
Drugs / interventions tested
- observational — full drug profile →
Conditions studied
- Cardiogenic Shock — all drugs for Cardiogenic Shock →
- Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Sponsor
Sociedad Argentina de Cardiología
Who can join
Adults 18 to 100, any sex, with Cardiogenic Shock or Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a Registry of the characteristics and clinical evolution of patients admitted for acute coronary syndromes (with or without st segment elevation) who present with cardiogenic shock or develop it during the hospitalization period. Cardiogenic shock is a rare pathology, but it constitutes the leading cause of mortality in patients hospitalized for acute infarction myocardium. Its incidence ranges between 7 and 10% of the cases of infarction1 and is associated with a mortality of 40-50% despite revascularization and the use of Intra-Aortic Counterpulsation Balloon. Most of the bibliography on this subject is North American and has a lot of years and the one currently published shows mostly the results of different ventricular supports that are not used routinely in our countries. So far there is no record that reports the reality of Latin America. Only in Argentina, a registry has been carried out (Re Na Shock) but more than 5 years have passed since its publication. In the last years have even changed the management guidelines for this pathology and have been published works that could have changed previous behaviors . This is a project of the Argentine Society of Cardiology to collect data epidemiological and current management of cardiogenic shock in Latin America.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05246683
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of observational
Trials testing the same drug.
- NCT06822764 — Mental Processes for Rating Pain Intensity · enrolling by invitation
- NCT06162234 — Wuhan High Myopia Study · recruiting
- NCT06066736 — Risks Factors and Outcome of Recurrences in Patients With Ventilator-Associated Pneumonias (REVAP) · completed
- NCT06403631 — Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis · recruiting
- NCT05768906 — (DIS)AGreement of Relatives Regarding Ethical End-of-life Decisions in ICU. · completed
Other recruiting trials for Cardiogenic Shock
Currently open trials in the same condition.
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07345559 — Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock · NA · recruiting
- NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
- NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
- NCT07309029 — Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR · recruiting
Other Sociedad Argentina de Cardiología trials
Trials by the same sponsor.
- NCT05199116 — National Registry of Cardiovascular Surgery in Argentine · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05246683 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sociedad Argentina de Cardiología
- Last refreshed: 18 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05246683.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing